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The amount and composition of lysophosphatidate pre- 
sent in different rat tissues have been estimated by 
an internal standard method in which a synthetic un- 
natural isomer (1-heptadecanoyl-rac.glycerol-3.phos. 
phate) was added to the total lipid extracts, and the 
fatty acid composition of purified lysophosphatidate 
was determined. Lipids from tissues were extracted 
under acidic conditions, and the lysophosphatidate was 
purified by solvent partitions followed by thin-layer 
chromatography in multiple solvent systems. The pu- 
rified lipid was shown to be 1-acyl-sn-glycerol-3- 
phosphate by chromatographic and chemical analysis, 
by its resistance to hydrolysis when treated with 
phospholipase A 2 and also by its complete conversion 
to 1-acyl-sn-glycerol when treated with alkaline 
phosphatase. The fatty acid consituents of this lipid 
were determined by gas.liquid chromatography of the 
derived methyl esters. The concentrations (nmol/g of 
tissue) of lysophosphatidate in various tissues were: 
86.2 • 4.2 in brain, 60.3 • 6.3 in liver, 46.4 "1" 6.5 in 
kidney, 30.6 ___ 5.0 in testis, 22.3 in heart and 19.3 in 
lung. Mostly (80%) saturated fatty acids were found 
to be present in this lyso lipid. A significantly high 
level of stearic acid was present in this lipid from all 
the tissues (50-60% in liver, kidney, brain and testis, 
and about 40% in heart and lung) compared to pAlmltic 
acid (10-15% in liver, kidney and brain and 25-30% in 
testis, heart and lung). The fatty acid compositions of 
phosphatidic acid, the putative product of lysophosphat- 
idate acylation, from different tissues were also deter- 
mined and palmitate was found to be the major satu- 
rated fatty acid. These results suggest that tissue lys~  
phosphatidic acid is not only formed by de novo bid 
synthesis but is also generated via the breakdown of 
phospholipids such as phosphoinositides. 
Lipids 24, 329-333 (1989). 
Lysophosphatidic acid (lysoPA) is a key intermediate 
for the biosynthesis of glycerolipids (1-3). This lipid 
is formed in three different subcellular compartments, 
either via direct acylation of glycerol-3-phosphate (G-3- 
P) in mitochondria and microsomes or via acylation of 
dihydroxyacetone phosphate (DHAP) in peroxisomes 
followed by reduction {2-4). This lyso lipid may also 
originate from the degradation of other lipids (5). The 
steady state concentrations of this important phosphol- 
ipid in different animal tissues and its fatty acid com- 
positions have not yet been reported in the literature. 
This is probably because during standard lipid extrac- 
tion method (6), at neutral pH, this acidic lyso lipid is 
lost with the aqueous wash and therefore escapes de- 
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tection (7). We recently developed a combined acid 
extraction and solvent partition method to isolate acyl 
DHAP from guinea pig liver and found that lysophosphat- 
idate is extracted and partitioned in the same manner 
(8). After purification by TLC and analysis it was found 
that guinea pig liver contained fairly high level of lysoPA 
(140 nmol/g) and stearic acid was the major fatty acid 
component (66%) of this lipid. We also estimated lysoPA 
in three different rat tissues by enzymatically measur- 
ing the sn-glycerol-3-phosphate released after alkaline 
methanolysis of partially purified lipid extracts and 
found it to be relatively high (50-90 nmol]g) (8). How- 
ever, in that work the loss incurred during purification 
of lysoPA was not considered and whether the lysoPA 
in rat tissues was also enriched in stearic acid had not 
been determined. Therefore, the present method of analy- 
sis of lysoPA in different tissues was developed where 
an internal standard was used to account for the loss 
of lysoPA during its extensive purification and for the 
quantitative determination and the fatty acid compo- 
sition of this polar lipid. These results are reported 
here. 
MATERIALS 
Gas-liquid chromatographic (GLC) reference mixture 
of saturated fatty acid methyl esters of different car- 
bon chains was purchased from Nu Chek Prep, Inc. 
(Elysian, Minnesota) and that of polyunsaturated fatty 
acids ~PUFA, No. 2, animal source} was from Supelco, 
Inc. (Bellefonte, Pennsylvania) and used for the identi- 
fication of unknown saturated and unsaturated fatty 
acids, n-Heptadecanoic acid was from Aldrich Chemi- 
cal Co. {Milwaukee, Wisconsin); the methyl ester of 
this compound showed a single peak on GLC chroma- 
togram. Authentic lipids including lysoPA, phosphat- 
idic acid (PAL 1- and 2-palmitoyl-sn-glycerol, phosphol- 
ipase A2 from Naja naja venom and alkaline phosphatase 
from E. coli were obtained from Sigma Chemical Co. 
{St. Louis, Missouri). 1-Heptadecanoyl DHAP was pre- 
pared from n-heptadecanoic acid and glycolic acid as 
described before {9). 1-Heptadecanoyl-rac-G-3-P, which 
was used as an internal standard during the present 
studies for estimation of lysoPA, was made by reduc- 
ing 1-heptadecanoyl DHAP by NaBH4 in ethanol at 
pH 7.5 for 2 hr at 37~ as described before (8). This 
synthesized material gave one spot on TLC in different 
solvent systems and was found to contain only hepta- 
decanoic acid as checked by GLC of the derived methyl 
ester. The fatty acid to phosphate ratio was 1:1. The 
phosphorus concentration of this material and other 
lipids was determined by the method of Ames and 
Dubin (10). Adult Sprague-Dawley male rats {200-250 
g) were purchased from Harlan Sprague-Dawley, Inc. 
(Indianapolis, Indiana) and fed standard diet (Purina 
Chow) and water ad libitum. Other materials were the 
same as described previously (8,9). 
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METHODS 
Extraction of lysoPA from tissues. Total lipids from 
liver, kidney, brain, testis, heart and lung of adult rats 
(150-200 g) were extracted by an acidic solvent extrac- 
tion method (8). The rats were anesthetized with di- 
ethyl ether, the tissues were removed and immediately 
(within 15 sec) frozen in an isopentane/dry ice bath 
and, if necessary, stored at -70~ The frozen tissues 
were weighed and quickly ground into small pieces 
with a pre-chiUed (-20~ mortar and pestle and im- 
mediately homogenized in chloroform/methanol/2M 
H3PO4 (1:1:0.05). During homogenization of the tis- 
sues, 25 nmol of synthetic 1-heptadecanoyl-rac-G-3-P 
per g of tissue was added to the homogenates. The 
lysoPA was separated from most other tissue lipids 
by partitioning the lipids between two phases, first at 
pH 4.4 where lysoPA was partitioned into the upper 
aqueous layer and then at pH 1.5 when lysoPA is 
extracted back into the lower chloroform layer by the 
methods previously described (8). 
Purification of lysoPA. This partially purified 
lysoPA was further purified to homogeneity by using 
three consecutive thin layer chromatographic systems. 
The lipid extract was put as a band on a preparative 
TLC plate (E. Merck, Silica Gel-60, 0.5 mm thick) along 
with an authentic standard lysoPA spot side-by-side 
and the plate was developed in the first solvent sys- 
tem, chloroform/methanol]acetic acid/5% sodium bisul- 
fite (100:40:12:4). The lipid bands were visualized un- 
der UV light after spraying the plate with Primuline 
(11). The lysoPA band was located by comparing its 
mobility to that of standard lysoPA (Rf -- 0.33) and 
the content of this band was recovered by scraping it 
out and extracting the scrapings three times with chlo- 
roform/methanol (1:1) containing HC1 (0.1M). The com- 
bined extract was washed with half volume of water 
to remove the acid. The lower layer containing the 
lysoPA was dried by blowing nitrogen, and the dried 
lipid was subjected to a second TLC using a basic 
solvent system i.e. chloroform/methanol]8 M NH4OH 
(60:40:5). The lysoPA (Rf -- 0.07) was recovered from 
the TLC plate as described above and then finally 
purified by TLC by using another solvent system of 
chloroform/methanol/acetic  acid/acetone/water 
(100:30:20:40:10) (12). The lysoPA (Rf --- 0.46) was 
extracted out from the TLC spot as described above 
and used for analysis. 
Hydrolysis by alkaline phosphatase. About 50 ~g 
of standard lysoPA or rat liver lysoPA (purified with- 
out the addition of the internal standard) dispersed in 
Tris buffer (0.15M, pH 8.5) by sonication was incu- 
bated with E. coli alkaline phosphatase (35 ~g, 1.5 U) 
in a final volume of 0.5 ml. The mixture was incubated 
at 37~ for 2 hr. The product was extracted using an 
acidic Bligh and Dyer extraction method (13). When 
necessary, the progress of the reaction was studied by 
taking out an aliquot of the reaction mixture, extract- 
ing the lipids under acidic conditions (8) and separat- 
ing them on TLC using chloroform/methanol]acetic acid] 
water (100:40:12:4). In this system the product monoacyl 
glycerol has an Rf of 0.88 and the Rf of lysoPA is 0.42. 
Separation of monoacylglycerols. The positional iso- 
mers of monoacyl glycerol(1-sn and 2-sn) were sepa- 
rated from each other by TLC on silica gel containing 
boric acid (14). The boric acid impregnation was done 
by immersing the plates (5 X 20 cm Merck Silica gel- 
60) in methanolic boric acid (12% w/v) for 30 min. The 
plates were air dried for 15 min, activated at l l0~ for 
30 min and used immediately. By this procedure, the 
TLC plate was found to contain boric acid about 10% 
of the weight of the adsorbent. The monoacylglycerols 
were separated from each other by using a solvent 
system of chloroform/acetone (90:10). The respective 
Rf values for 1-palmitoyl and 2-palmitoyl-sn-glycerol 
were 0.12 and 0.20. 
Extraction and purification of PA. The lower, 
washed chloroform layer which was saved during the 
lipid partitioning process (8) was concentrated under 
a stream of N2. From this total lipid extract PA was 
isolated by two-dimensional TLC on a preparative plate 
(0.5 mm thick E. Merck Silica gel 60) using the solvent 
mixture of chloroform/methanol]8 M HN4OH (17:7:1) 
in the first dimension followed by chloroform/methanol/ 
acetic acid]water (80:40:7.4:1.2) in the second dimen- 
sion essentially as described by Pumphrey (15). Puri- 
fied PA migrated as a single spot having Rf of 0.04 in 
the first and 0.55 in the second solvent. 
Treatment with phospholipase Az To 100 pg of 
PA or lysoPA dissolved in 0.5 ml of diethyl ether/ 
methanol (98:2), 50 ~1 of a solution of lyopbillzed Naja 
naja venom (1 mg/0.5 ml of 0.3 M Tris-HC1, pH 7.5 
containing 20 mM CaC12) was added. The mixture was 
vortexed vigorously for 30 sec and then incubated at 
room temperature for 3-4 hr with gentle magnetic stir- 
ring under N2 essentially as described by Wells and 
Hanahan (16). After the reaction, most of the ether and 
methanol were evaporated off under N2 and the prod- 
uct was dissolved in 2 ml of chloroform/methanol (1:1), 
followed by the addition of 0.8 ml of water containing 
0.1M HC1. The lower chloroform layer was washed 
with chloroform/methanol/water (1:12:12). An aliquot 
of the lipid extract was put on TLC plate and devel- 
oped with chloroform/methanol/acetic  acid/water 
(100:40:12:4) for identification of the products by com- 
paring the Rf values of standard compounds applied 
side by side. The Rf values of PA, lysoPA and free 
fat ty acid in this solvent system were 0.77, 0.42 and 
0.98, respectively. 
Preparation and analysis of fatty acid methyl es- 
ters from lysoPA and PA. Fat ty  acid methyl esters 
were prepared from these lipids by alkaline methanoly- 
sis (17) with modification. In a screw-capped tube, a 
portion of lipid solution (- 15 ~g of lipid phosphorus) 
was dried down under N2. One ml of 0.2 M NaOH in 
methanol and 2.0 ml of chloroform were added. The 
reaction mixture was mixed well and left at room tem- 
perature. After one hr of incubation, 0.75 ml of 0.35 N 
acetic acid was added, mixed well, and the phases were 
separated by centrifugation. Upper layer was removed 
and the lower layer was washed with 2 ml of 0.9% 
NaC1/methanol mixture (1:1). The methyl esters pre- 
sent in the final chloroform layer were purified by TLC 
using a solvent system of n-hexane/ether/acetic acid 
(50:50:2). The purified ester (Rf = 0.67} was extracted 
from TLC powder by three extractions with diethyl 
ether. After removing the ether by blowing N 2, the 
sample was dissolved in a small volume of n-hexane 
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and analyzed in a Hewlet t -Packard gas chromatograph,  
Model No. 5710A, equipped with flame ionization de- 
tector  and an electronic integrator  (Spectra Physics). 
The s ta t ionary phase was 15% Silar 10C supported on 
Gas Chrom R in a glass-lined stainless steel analytical 
column {183 cm • 0.32 cm) and the temperature  pro- 
gramming of 150-220~ was used for the GLC run. 
The components  of methyl  esters were identified by 
comparing the retention times with those of standards.  
Estimation of lysoPA in tissues. The amount  of 
lysoPA present  in different tissues was evaluated from 
the relative amount  of 17:0 in the fa t ty  acid mixtures 
derived from the lipid. Because the endogenous 17:0 
content  of lysoPA isolated from different tissues was 
found to be very low {<1% of total  fa t ty  acids), it was 
assumed tha t  all the 17:0 present  in the final GLC 
analysis of the fa t ty  acid composition of lysoPA was 
from the heptadecanoyl  GP added {25 nmol]g tissue) 
during the lipid extract ion process. This and the as- 
sumption that  the proportional loss of this internal 
s tandard during purification is the same as the other 
molecular species of lysoPA were used to calculate the 
lysoPA content  of different tissues. For example, nmol 
lysoPA/g tissue = [(100 --  wt % 17:0)/wt % 17:0] • 
25. The amount  of each individual fa t ty  acid present  
in lysoPA can also be calculated this way. 
All other methods were the same as described pre- 
viously (8,9). Lipids were stored, when necessary, at 
- 7 0 ~  under N2. 
RESULTS 
Isolation and characterization of lysoPA. The lysoPA 
purified by  the above method migrated as a single spot 
with the mobil i ty same as s tandard  lysoPA in two 
other TLC systems: (a) chloroforrrdmethanol/2-propanol] 
0 .25% aqueous  p o t a s s i u m  ch lo r ide / e thy l  a c e t a t e  
(30:9:25:6:18) (18) (Rf = 0.15) and (b) chloroform/ 
methanol/acetic acid/water (100:40:12:4) (Rf = 0.42). 
When analyzed (8), the phosphorus/sn-glycerol-3-P/ 
fa t ty  acid molar ratio in different lysoPA tissue sam- 
ples was found to be 1.0:1.0:1.0. From these criteria 
the isolated lysoPA was judged to be pure. The recov- 
ery of lysoPA from each TLC purification was 80-90% 
as measured by using radioactive lysoPA (8). The over- 
all recovery of lysoPA from the crude lipid ext rac t  
varies from 50-60% as indicated by  the recovery of the 
internal s tandard (17:0) by  GLC. 
The lysoPA isolated from liver and kidney seemed 
to be 1-acyl isomer since it was not  hydrolyzed by 
phospholipase A 2 as indicated by  the absence of free 
f a t ty  acid as a product  when analyzed on the TLC plate 
and the total  phosphorus content  of tysoPA before and 
after the enzymatic t rea tment  was the same. This is 
confirmed by  hydro lyz ing  the lysoPA by alkaline 
phosphatase and analyzing the product. The lysoPA 
from liver, like the s tandard lysoPA, was completely 
h y d r o l y z e d  in 2 hr when  t r e a t e d  wi th  a lkal ine  
phosphatase  as described in Methods. The resulting 
product ,  i.e., monoacyl  glycerol, when chromatogra-  
phed on 10% boric acid impregnated silica gel plate 
migrated as a single spot with authentic 1-palmitoyl- 
sn-glycerol. There  was no spot  corresponding to 2- 
palmitoyl-sn-glycerol. 
T A B L E  1 
Lysophosphatidate Content of Different Rat Tissues a 
LPA 
Tissue (nmol/g of tissue) • S.D. 
Liver 60.3___6.3 (n=4) 
Kidney 46.4___6.5 (n=4} 
Brain 86.2___4.2 (n=3) 
Testis 30.6• (n=3) 
Heart 19.5, 25.1 a 
Lung 17.0, 21.6 a 
aThe contents of LPA in different tissues of rat were estimated 
by GLC analysis of the fatty acid methyl esters including the 
internal standard methyl heptadecanoate {17:0) as described in 
the text. 
n, Number of experiment; a, results of two experiments. 
Tissue distribution of lysoPA. As shown in Table 
1, the contents  of lysoPA in different tissues of ra t  
ranged from 20-90 nmol/g of tissue. Brain contained 
the highest level of this lipid (78-92 nmol/g of tissue) 
compared  to other  organs (20-60 nmol/g of tissue). 
Very little variation was observed in the lysoPA con- 
tent  of corresponding tissues from different animals. 
This is probably because of the use of adult animals 
of the same age group and using identical conditions 
to harvest  the tissues. The amount  of lysoPA present, 
however, is sufficient to isolate it from a small amount  
(0.5 g) of tissues and accurately analyze its fa t ty  acid 
composition. 
The presence of alkali stable lysoPA, i.e., lysoPA 
which may contain ether bond (instead of ester  bond) 
was investigated by using ra t  kidney lysoPA. The phos- 
phorus concentration before and after alkaline metha- 
nolysis of lysoPA was determined. The results indi- 
cated tha t  about  10% of kidney lysoPA was alkali 
stable. The nature  of this alkali stable lipid, however, 
was not  investigated further. This is most  probably 
alkyl G-3-P as any alkenyl G-3-P will be degraded by 
the repeated acidic ex t rac t ions  used to pur i fy  the 
lysoPA. 
Fatty acid compositions of lysoPA from different 
tissues. Table 2 presents the fa t ty  acid compositions 
of lysoPA from six different tissues of rat. Basically, 
T A B L E  2 
Fatty  Acid Compositions of LPA  in Different Tissues of Rat a 
Composition in wt % 
Fatty acid Liver Kidney Brain Testis Heart Lung 
14:0 9.5 5.2 0.5 tr 0.6 tr 
16:0 16.0 13.6 9.9 31.5 26.1 28.4 
18:0 50.6 59.9 51.3 56.6 35.6 42.6 
18:1{n-9} 17.3 10.3 31.6 9.2 25.4 20.8 
18:2{n-6} 5.2 6.9 tr 1.6 6.2 7.1 
18:3(n-3} -- -- 5.0 -- 1.5 1.0 
20:4{n-6) 1.4 2.1 1.5 0.9 tr tr 
aThe methyl esters were prepared from the purified LPA of 
different tissues containing l-O-heptadecanoyl-rae-G-3-P as in- 
ternal standard and analyzed by GLC as described in the text. 
The wt % of each fatty acid was calculated from the known 
amount of the internal standard {17:0}. The data are the aver- 
ages {ranges _ 3%) of three experiments. 
tr, Trace, less than 0.1%. 
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16:0, 18:0 and 18:1 were the three major components  
of lysoPA from all tissues. As can be seen (Table 2), 
18:0 was the major fa t ty  acid present  in the lysoPA, 
e.g., more than half (50-60%) of total  fa t ty  acids were 
composed of 18:0 in the lysoPA isolated from liver, 
kidney, brain and testis. The ratio of 18:0/16:0 is also 
very  high (3 to 5) in most  of the tissues (Table 2). The 
fa t ty  acid compositions of lysoPA from all these tis- 
sues were found to be very  similar to guinea pig liver 
lysoPA which also contained very  high amounts  of 
stearic acid (65.9%) (81. 
Purification and fatty acid composition of PA from 
different tissues. We also analyzed the fa t ty  acid com- 
positions of PA, the puta t ive  biosynthetic product  from 
lysoPA, isolated from different tissues. Although the 
fa t ty  acid compositions of ra t  liver and brain PA have 
been reported previously (19, 20), no information is 
available regarding  the composi t ion of PA of o ther  
organs. PA was isolated by  two dimensional TLC us- 
ing the same solvent systems as described by Pumphrey  
(15). An excellent and reproducible separation of this 
lipid from all other lipids was achieved; however, in- 
stead of the double spots for PA reported by  Pumphrey  
(15), a single spot was found. This difference is prob- 
ably because under  the acidic lipid ex t rac t ion  used 
here, all the tissue phosphat idates  were converted to 
the free acid form which migrated as a single spot on 
the TLC plate. 
The amounts  of PA present  in various organs of 
rat, human and other animals have been reported by  
other workers (21--23). The fa t ty  acid compositions of 
PA of different tissues of ra t  are presented in Table 3. 
I t  should be noted that ,  except in the case of brain and 
heart,  the levels of 16:0 in the PA of different tissues 
were much higher than  tha t  of 18:0. For  example, the 
ratio of 16:0/18:0 in brain was 0.53, which is lower than 
tha t  in liver (1.48), kidney (1.25), tes t is  (2.62) lung 
(1.31) and heart  (0.91) (Table 3). The values of this ratio 
as calculated from literature reports  are 2.2 (19) and 
0.87 (20) for ra t  liver and brain, respectively. Among 
the m o n a  and polyunsatura ted fa t ty  acids, 18:1, 18:2 
and 20:4 were the major components;  however, in brain, 
a significant amount  of 18:3 (6.0%) was also present. 
Possmayer  et  al. have shown tha t  ra t  liver PA 
contained 51% of 16:0 and 33% of 18:0 at the sn-1 
position of glycerol (19). We determined the positional 
distribution of fa t ty  acids in ra t  kidney PA by stereospe- 
cific hydrolysis  with phospholipase A 2 and then ana- 
lyzing the f a t t y  acid composi t ion of the resul t ing  
lysoPA. The results showed tha t  16:0 is present  at a 
relatively higher amount  (53%) than 18:0 (24%) at the 
sn-1 position of ra t  kidney PA. 
DISCUSSION 
The use of the internal standard, 1-heptadecanoyl glyc- 
erol-3-P, was advantageous for the simultaneous quan- 
tification of the amount  and fa t ty  acid composition of 
the lipid. Since, like any other internal s tandard method 
a quant i ta t ive recovery of lysoPA was not  necessary, 
the estimation was more easily done than any other 
method. This method should have a general applicabil- 
i ty  for the accurate analysis of any tissue lipid as the 
s tandards containing unnatural  f a t ty  acids can be eas- 
TABLE 3 
Fatty  Acid Compositions of P A  in Different Tissues of Rat a 
Composition in wt % 
Fatty acid Liver Kidney Brain Testis Heart Lung 
14:0 1.8 3.8 tr 0.3 0.2 0.8 
16:0 23.2 24.4 10.7 38.0 18.5 23.7 
16:1(n-9) 4.0 3.7 0.8 2.2 2.1 3.5 
18:iso 1.0 0.2 0.5 0.2 -- 0.5 
18:0 15.6 19.6 20.1 14.5 20.3 18.0 
18:1(n-9) 20.1 12.2 33.0 17.5 14.6 15.7 
18:2(n-6) 21.7 8.8 3.1 4.3 20.3 14.3 
20:0 -- 2.2 2.0 3.8 3.0 2.6 
18:3{n-3) 1.5 0.2 6.0 -- -- 1.6 
18:4(n-3) -- -- 0.8 -- 0.2 tr 
20:2(n-6) 0.3 0.2 0.8 tr 0.4 0.5 
20:3(n-6) 0.4 2.4 2.8 1.6 1.5 1.7 
20:4(n-6} 6.3 10.0 9.7 9.5 6.6 6.6 
20:5(n-3) 0.4 -- 0.6 -- 0.3 0.6 
22:4{n-6) -- 0.9 2.8(?) -- tr 0.9 
22:5(n-3) -- -- -- 3.7 (?) -- 0.7 
2 2 : 6 ( n - 3 )  - -  - -  0 . 3  - -  2 . 2  0 . 9  
apA from different tissues were isolated by two dimensional 
TLC and the total fatty acid contents were analyzed by GLC 
(see text). The data are the averages {ranges _+ 5%) of two 
experiments. 
tr, Trace, less than 0.1%. 
fly synthesized by chemical or enzymatic methods. 
As described above, lysoPA isolated from differ- 
ent  tissues was found to be pure by chromatographic 
and chemical analysis. The lysoPA of ra t  liver was 
characterized as 1-acyl-sn-glycerol-3-P by the follow- 
ing criteria: {a) After  alkaline methanolysis  of the lipid, 
the products ,  i.e., f a t t y  acid methyl  es ters  and sn- 
glycerol-3-P formed were in 1:1 molar proport ion.  
(b) Hydrolysis  by alkaline phosphatase yielded 1-acyl- 
sn-glycerol as the sole lipid product.  (c) The lipid is not  
hydrolyzed by phospholipase A2. Van Deenen and de 
Haas (24) have shown tha t  lysophosphatides (2-acyl) 
are hydrolyzed by snake venom phospholipase A2. 
Though the exact  s t ructure  of lysoPA of organs 
other  than liver was not  determined, the similarity in 
the chromatographic  migra t ion ra te  with ra t  liver 
lysoPA, formation of 1:1 molar proportion of fa t ty  acid 
and sn-glycerol-3-P after  alkaline hydrolysis and the 
presence of mainly saturated fa t ty  acids in the purified 
lysoPA (Table 2) indicate tha t  this lipid in all t issues 
is predominantly 1-acyl-sn-glycerol-3-P. 
The tissue concentrations of lysoPA, as reported 
here, are relatively high 120-90 nmoYg of tissue) com- 
pared to similar lipid biosynthetic intermediates such 
as acyl D H A P  (2-10 nmol]g of tissue} (8) or CDP dia- 
cylglycerol (9-15 nmol/g of tissue) (25) but  are lower 
than the corresponding amounts  of phosphatidic ac id  
present  in these tissues {150-200 nmol/g of tissue) (21, 
22). LysoPA is biosynthesized in three different subcel- 
lular compar tments ,  i.e., mitochondria ,  peroxisomes 
and endoplasmic reticulum, but  only in endoplasmic 
re t iculum it is enzymat ica l ly  acyla ted to PA (2, 3). 
This may  account for the relatively high steady-state 
concentrat ion of lysoPA in different tissues because 
the mitochondrial and peroxisomal-derived lysoPA must  
be t ranspor ted to the endoplasmic reticuhim for lipid 
biosynthesis.  Also, from the high stearate content  of 
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lysoPA (Table 2), it seems tha t  a large fraction of 
tissue lysoPA originates from sources other than via 
the biosynthetic routes. This is because biosynthetically- 
derived lysoPA should have most ly 16:0, as both glyc- 
erophosphate acyltransferase and dihydroxyacetone phos- 
phate  acyl t ransferase  have been shown to preferen- 
tially utilize 16:0 rather than 18:0 for the acylation of 
GP and DHAP,  respectively {26-28}. The predominance 
of 16:0 at the sn-1 position of PA as shown here and 
by other workers (19) also indicates tha t  biosynthetic 
lysoPA should contain a relatively higher amount  of 
16:0 than 18:0. Therefore, our results suggest  tha t  a 
major fraction of lysoPA is probably formed via cata- 
bolic breakdown of lipids. One such possibility is the 
formation of this lipid from phosphoinositides which 
have most ly 18:0 at the sn-1 position (20, 29, 30}. La- 
petina and co-workers have shown that  by the consecu- 
tive actions of phospholipase C, diacylglycerol kinase 
and PA-specific phospholipase A2, the phosphoinosi- 
tides are converted to lysoPA (5, 31). Therefore, it is 
possible tha t  a portion of the tissue lysoPA originates 
from such receptor mediated breakdown of membrane 
lipids (32, 33). Further  experiments such as the effects 
of chronic stimulation of phosphoinositide~linked re- 
ceptor on the concentration and composition of lysoPA 
in cells would be useful to establish the source and 
function of this polar lipid in cellular metabolism. 
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